UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported) July 24, 2015
 
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
 
1-15525
 
36-4316614
(State or other jurisdiction
of incorporation)
 
(Commission
file number)
 
(IRS Employer
Identification No.)
 
One Edwards Way, Irvine, California
 
92614
(Address of principal executive offices)
 
(Zip Code)
(949) 250-2500
Registrant’s telephone number, including area code
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-Commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o
Pre-Commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 





Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b)
On July 24, 2015, Robert A. Ingram retired from the board of directors of Edwards Lifesciences Corporation.
On July 30, 2015, Edwards issued a press release announcing his retirement. A copy of the press release is furnished as Exhibit 99.1.
Item 9.01    Financial Statements and Exhibits.
(d)    Exhibits

99.1
Press Release dated July 30, 2015







SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: July 30, 2015
 
 
EDWARDS LIFESCIENCES CORPORATION
 
 
 
 
 
 
 
By:
/S/ Denise E. Botticelli
 
 
 
 
 
Denise E. Botticelli
 
 
Vice President, Associate General Counsel, and Secretary






Exhibit Index
 
Exhibit
Number
 
Description
 
 
 
99.1
 
Press Release dated July 30, 2015









Edwards Lifesciences Corporation
One Edwards Way Irvine, CA USA 92614
Phone: 949.250.2500 Fax: 949.250.2525
www.edwards.com



FOR IMMEDIATE RELEASE

Media Contact: Sarah Huoh, 949-250-5070
Investor Contact: David K. Erickson, 949-250-6826

EDWARDS ANNOUNCES BOARD CHANGE
 
IRVINE, Calif., July 30, 2015 - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that Robert A. Ingram has retired from the company’s Board of Directors.
“Bob is an ardent champion for innovation in the lifesciences industry, and it has been a true privilege to have him on Edwards’ board as we pursue our focused innovation strategy,” said Michael A. Mussallem, Edwards’ chairman and CEO. “Bob has provided a valuable perspective to our board, drawing on his experience and extensive relationships as a global leader for the pharmaceutical industry. We are deeply grateful for his years of service, his focus on patients and his thoughtful guidance to Edwards, and wish him all the best in the future.”
Ingram joined Edwards’ board in 2003 and has chaired the Compensation and Governance Committee, as well as served on the Audit Committee.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring.  Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring, enabling them to save and enhance lives. Additional company information can be found at edwards.com. 
Edwards, Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation.
 
# # #



Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Edwards Lifesciences Charts.
Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Edwards Lifesciences Charts.